rs11292716
|
|
Aspartate aminotransferase measurement
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Connecting genetic risk to disease end points through the human blood plasma proteome.
|
28240269 |
2017 |
rs1157745
|
|
Blood Protein Measurement
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
rs2057681
|
|
Serum albumin measurement
|
G |
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide assessment of variability in human serum metabolism.
|
23281178 |
2013 |
rs2057681
|
|
paraoxonase activity
|
G |
0.700 |
GeneticVariation
|
GWASDB |
Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk.
|
22982463 |
2012 |
rs2237583
|
|
paraoxonase activity
|
|
0.700 |
GeneticVariation
|
GWASDB |
Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL.
|
23160181 |
2013 |
rs3917502
|
|
Triglycerides measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
rs3917510
|
|
Serum total cholesterol measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
rs3917532
|
|
Blood Protein Measurement
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
rs3917539
|
|
Blood Protein Measurement
|
TAA |
0.700 |
GeneticVariation
|
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
rs3917545
|
|
Blood Protein Measurement
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
rs3917549
|
|
Blood Protein Measurement
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
rs662
|
|
Blood Protein Measurement
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
rs662
|
|
Enzyme activity finding
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
rs662
|
|
CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO
|
C |
0.700 |
SusceptibilityMutation
|
CLINVAR |
|
|
|
rs662
|
|
CORONARY ARTERY SPASM 2, SUSCEPTIBILITY TO
|
C |
0.700 |
SusceptibilityMutation
|
CLINVAR |
|
|
|
rs705379
|
|
Blood Protein Measurement
|
A |
0.700 |
GeneticVariation
|
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
rs757158
|
|
Aspartate aminotransferase measurement
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Connecting genetic risk to disease end points through the human blood plasma proteome.
|
28240269 |
2017 |
rs854560
|
|
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5 (finding)
|
T |
0.700 |
SusceptibilityMutation
|
CLINVAR |
|
|
|
rs854560
|
|
CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO
|
T |
0.700 |
SusceptibilityMutation
|
CLINVAR |
|
|
|
rs854560
|
|
Enzyme activity finding
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
rs854572
|
|
paraoxonase activity
|
C |
0.700 |
GeneticVariation
|
GWASDB |
Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk.
|
22982463 |
2012 |
rs662
|
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.100 |
GeneticVariation
|
BEFREE |
Therefore, Q192R polymorphism was more correlated with type 2 diabetes mellitus.
|
31102685 |
2019 |
rs662
|
|
Ischemic stroke
|
|
0.100 |
GeneticVariation
|
BEFREE |
In summary, this meta-analysis proved that PON1 rs854560 polymorphism could be used to identify individual with elevated susceptibility to IS, whereas rs662 polymorphism could be used to identify individual with elevated susceptibility to CAD.
|
31302193 |
2019 |
rs662
|
|
Coronary Artery Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
In summary, this meta-analysis proved that PON1 rs854560 polymorphism could be used to identify individual with elevated susceptibility to IS, whereas rs662 polymorphism could be used to identify individual with elevated susceptibility to CAD.
|
31302193 |
2019 |
rs662
|
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.100 |
GeneticVariation
|
BEFREE |
PON1 (Q192R and L55M) polymorphisms may play a crucial role in pathogenesis and susceptibility of insulin resistance thus leads to the development of type 2 diabetes in South Indian population.
|
29409844 |
2018 |